文献速递慢性肾脏病肾血管病与高血压

代谢综合征与高滤过及长期GFR下降的关联

The Association Between Metabolic Syndrome, Hyperfiltration, and Long-Term GFR Decline in the General Population.
PubMed 文献 · Kidney Int Rep · 2023-07-01

在RENIS研究中,1551名50-63岁无糖尿病、心血管病或肾脏病的普通人群接受基线及11年随访期间两次碘海醇清除率测定的GFR。代谢综合征与基线高滤过(OR 2.4)及更陡的GFR下降率相关,合并高滤过者下降更明显。

要点

  • 代谢综合征与基线高滤过独立相关(OR 2.4,95%CI 1.7-3.5)。
  • 代谢综合征者长期GFR下降率更陡(-0.30 ml/min/1.73m2/年)。
  • 代谢综合征合并高滤过者GFR下降达-0.83 ml/min/1.73m2/年。

核心结论

  • 在无糖尿病的普通人群中,代谢综合征与高滤过风险增加及长期GFR下降更陡相关。
  • 代谢综合征合并基线高滤过者GFR下降幅度更大,但交互作用无统计学意义(P=0.2)。
  • 需要随机对照试验探讨治疗高滤过能否预防代谢综合征患者GFR丢失。

研究设计与样本

  • RENIS研究纳入1551名50-63岁无糖尿病、心血管疾病或肾脏病的普通人群代表。
  • 基线及11年随访期间两次使用碘海醇清除率测定GFR。
  • 基线高滤过定义为按性别、年龄和身高调整后绝对GFR(ml/min)高于第90百分位数。
  • 代谢综合征定义为腰围增加且具备高血压、高血糖、甘油三酯升高、HDL胆固醇降低中2项危险因素。
  • GFR下降率使用线性混合模型计算。

主要发现

  • 代谢综合征与基线高滤过相关(OR 2.4;95% CI:1.7-3.5,P < 0.001)。
  • 代谢综合征与随访期间更陡的GFR下降率相关(-0.30 [-0.43 至 -0.16] ml/min per 1.73 m2/yr)。
  • 与无代谢综合征者相比,代谢综合征合并基线高滤过者GFR下降为-0.83(95% CI:-1.13 至 -0.53)ml/min per 1.73 m2/yr。
  • 代谢综合征无高滤过者GFR下降为-0.15(-0.30 至 0.00)ml/min per 1.73 m2/yr,交互作用P = 0.2。

临床怎么用

  • 在无糖尿病的普通人群中,代谢综合征患者应关注基线高滤过及长期GFR下降风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: One-quarter of adults worldwide meet the criteria of metabolic syndrome (MetS). MetS increases the risk of diabetes, chronic kidney disease (CKD), and cardiovascular disease. However, the association between MetS, hyperfiltration, and long-term glomerular filtration rate (GFR) decline in the general population is unknown. METHODS: In the Renal Iohexol Clearance Survey (RENIS), we investigated 1551 people aged 50 to 63 years; representative of the general population without diabetes, cardiovascular disease, or kidney disease. The GFR was measured using iohexol clearance at baseline and twice during 11 years of follow-up. Hyperfiltration at baseline was defined as an absolute GFR (ml/min) above the 90th percentile adjusted for sex, age, and height, because these variables correlate with nephron number. MetS was defined as increased waist circumference and 2 risk factors among hypertension, hyperglycemia, elevated triglycerides, and low high density lipoprotein (HDL)-cholesterol levels. The GFR decline rate was calculated using linear mixed models. RESULTS: MetS was associated with hyperfiltration at baseline (odds ratio [OR] 2.4; 95% CI: 1.7-3.5, P < 0.001) and a steeper GFR decline rate during follow-up (-0.30 [-0.43 to -0.16] ml/min per 1.73 m2/yr). Compared to those without MetS, GFR decline was -0.83 (95% CI: -1.13 to -0.53) ml/min per 1.73 m2/yr in those with MetS and baseline hyperfiltration and -0.15 (-0.30 to 0.00) in those MetS without hyperfiltration, P = 0.2 for interaction. CONCLUSIONS: In the nondiabetic general population, those with MetS had an increased OR of hyperfiltration and steeper long-term GFR decline. Randomized controlled trials are needed to explore whether treatment of hyperfiltration can prevent loss of GFR in persons with MetS.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bystad EW, Stefansson VTN, Eriksen BO, et al. The Association Between Metabolic Syndrome, Hyperfiltration, and Long-Term GFR Decline in the General Population. Kidney Int Rep. 2023. PMID: 37705899. doi:10.1016/j.ekir.2023.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。